Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial

Affiliations

¹ Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
² Renal Transplant Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
³ Division of Nephrology and Transplantation, Department of Internal Medicine, Erasmus MC Transplant Institute, Erasmus MC, Rotterdam, The Netherlands.
⁴ Division of Nephrology, Department of Internal Medicine, Leiden Transplant Center, Leiden University Medical Center, Leiden University, Leiden, The Netherlands.
⁵ Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.
⁶ Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
⁷ Department of Nephrology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Jan-Stephan F Sanders et al. J Am Soc Nephrol. 2025.

. 2025 Nov 7.

doi: 10.1681/ASN.0000000924. Online ahead of print.

¹ Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
² Renal Transplant Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
³ Division of Nephrology and Transplantation, Department of Internal Medicine, Erasmus MC Transplant Institute, Erasmus MC, Rotterdam, The Netherlands.
⁴ Division of Nephrology, Department of Internal Medicine, Leiden Transplant Center, Leiden University Medical Center, Leiden University, Leiden, The Netherlands.
⁵ Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.
⁶ Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
⁷ Department of Nephrology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

No abstract available

Keywords: clinical trial; immunosuppression; kidney transplantation; survival analysis; tacrolimus.

References

1. Peters-Sengers H, Berger SP, Heemskerk MB, et al. Stretching the limits of renal transplantation in elderly recipients of grafts from elderly deceased donors. J Am Soc Nephrol. 2017;28(2):621–631. doi:10.1681/ASN.2015080879 - DOI
1. Tegzess E, Gomes Neto AW, Pol RA, et al. Comparative survival of elderly renal transplant recipients with a living donor versus a deceased donor: a retrospective single center observational study. Transpl Int. 2021;34(12):2746–2754. doi:10.1111/tri.14130 - DOI
1. McKay D, Jameson J. Kidney transplantation and the ageing immune system. Nat Rev Nephrol. 2012;8(12):700–708. doi:10.1038/nrneph.2012.242 - DOI
1. Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B. Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int. 2001;59(4):1539–1543. doi:10.1046/j.1523-1755.2001.0590041539.x - DOI
1. Neri F, Furian L, Cavallin F, et al. How does age affect the outcome of kidney transplantation in elderly recipients? Clin Transplant. 2017;31(10):e13036. doi:10.1111/ctr.13036 - DOI